Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
XMD17 109 REF: IN-DA009CFRCAS: 1435488-37-1 | 98% | To inquire | Tue 07 Jan 25 | |
XMD17-109 REF: TM-T1842CAS: 1435488-37-1 | 98.86% - 99.75% | 41.00 €~527.00 € | Tue 14 Jan 25 | |
XMD17-109 REF: 54-BISN0221CAS: 1435488-37-1 | - - - | 182.00 €~1,514.00 € | Tue 14 Jan 25 | |
XMD17-109 REF: 3D-KHC48837CAS: 1435488-37-1 | Min. 95% | To inquire | Tue 18 Feb 25 | |
ERK5-IN-1 REF: TR-E615300CAS: 1435488-37-1 | - - - | - - - | Discontinued product |
Ref: IN-DA009CFR
5mg | 99.00 € | ||
25mg | 249.00 € | ||
50mg | 561.00 € | ||
100mg | To inquire | ||
250mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
XMD17-109
CAS:1435488-37-1
XMD17-109 (ERK5-IN-1) is a new selective ERK-5 inhibitor (EC50: 4.2 uM, HEK293 cells).
Formula:
C36H46N8O3
Purity:
98.86% - 99.75%
Color and Shape:
Solid
Molecular weight:
638.8
Ref: TM-T1842
1mg | 41.00 € | ||
2mg | 52.00 € | ||
5mg | 85.00 € | ||
10mg | 142.00 € | ||
25mg | 217.00 € | ||
50mg | 350.00 € | ||
100mg | 527.00 € | ||
1mL*10mM (DMSO) | 110.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
Ref: 54-BISN0221
10mg | 182.00 € | ||
25mg | 347.00 € | ||
50mg | 577.00 € | ||
100mg | 963.00 € | ||
250mg | 1,514.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
XMD17-109
CAS:1435488-37-1
XMD17-109 is a drug that inhibits the mitogen-activated protein kinase (MAPK) pathway, which is a …
Formula:
C36H46N8O3
Purity:
Min. 95%
Molecular weight:
638.8 g/mol
Ref: 3D-KHC48837
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
ERK5-IN-1
CAS:1435488-37-1
Applications ERK5-IN-1 is a potent selective ERK5 inhibitor, inhibiting EGFR-induced ERK5 autophosphorylation and ERK5 enzymatic …
Formula:
C38H46N8O3
Color and Shape:
Yellow to Dark Yellow Solid
Molecular weight:
638.8
Ref: TR-E615300
5mg | Discontinued | Request information | |
25mg | Discontinued | Request information | |
100mg | Discontinued | Request information |